Index of reports
> Cases with Confusional State (15)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to MS Contin (Morphine) where reactions include confusional state. The selected reports were submitted to the FDA during the sample period of about a year.
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 39 year old male
Reported by a consumer/non-health professional from Canada on 2012-06-08
Patient: 39 year old male
Reactions: Speech Disorder, Confusional State, Hyperaesthesia, Pain, Drug Withdrawal Syndrome, Drug Dependence, Somnolence, Tremor
Drug(s) suspected as cause:
Morphine Sulfate
Dosage: 5 mg, unk
Indication: Pain
MS Contin
Indication: Pain
Morphine Sulfate
Indication: Pain
Morphine Sulfate
Dosage: 500 mg, daily
Other drugs received by patient: Opium / Naloxone TAB
Possible MS Contin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29
Patient: female
Reactions: Confusional State, Incorrect Dose Administered, Gait Disturbance, Hallucination, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: 30 mg, 2x/day
Administration route: Oral
Revlimid
Dosage: 5 mg, 1x/day
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-08-24
Other drugs received by patient: Neurontin; Percocet
Possible MS Contin side effects in male
Reported by a physician from United States on 2012-04-16
Patient: male
Reactions: Confusional State, Prostate Cancer Metastatic, Multiple Drug Overdose, Respiratory Depression, Drug Abuse
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: 100 mg, 2x/day
Administration route: Oral
Indication: Pain
Start date: 2011-02-01
Morphine Sulfate
Dosage: 30 mg, every 4-6 hours as needed
Administration route: Oral
Indication: Pain
Start date: 2011-02-01
Possible MS Contin side effects in male
Reported by a physician from United States on 2012-04-11
Patient: male
Reactions: Confusional State, Prostate Cancer Metastatic, Respiratory Depression, Multiple Drug Overdose, Drug Abuse
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: 100 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-02-01
Morphine Sulfate
Dosage: 30 mg, q4- 6h prn
Administration route: Oral
Indication: Pain
Start date: 2011-02-01
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 79 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-12
Patient: 79 year old male
Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
MS Contin
Possible MS Contin side effects in 53 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-01
Patient: 53 year old female
Reactions: Neurotoxicity, Myoclonus, Confusional State, Drug Effect Decreased, Sedation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fentanyl
Indication: Pain
Fentanyl
Hydromorphone HCL
Morphine
Administration route: Oral
Indication: Pain
MS Contin
Administration route: Oral
Morphine
Administration route: Oral
Fentanyl
Fentanyl
Methadone Hydrochloride
Administration route: Oral
Indication: Pain
MS Contin
Administration route: Oral
Indication: Pain
Methadone Hydrochloride
Administration route: Oral
Hydromorphone HCL
Indication: Pain
Hydromorphone HCL
Possible MS Contin side effects in 83 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2011-11-28
Patient: 83 year old male
Reactions: Confusional State, Vomiting, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
MS Contin
Other drugs received by patient: Temesta / 00273201 /; Irbesartan
Possible MS Contin side effects in 53 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-16
Patient: 53 year old female
Reactions: Confusional State, Neurotoxicity, Myoclonus, Drug Effect Decreased, Sedation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
MS Contin
Indication: Pain
Methadone HCL
Administration route: Oral
MS Contin
Methadone HCL
Administration route: Oral
Indication: Pain
Hydromorphone HCL
Indication: Pain
Fentanyl
Indication: Pain
Hydromorphone HCL
Morphine
Administration route: Oral
Fentanyl
Fentanyl
Hydromorphone HCL
Fentanyl
Morphine
Administration route: Oral
Indication: Pain
Possible MS Contin side effects in 53 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-24
Patient: 53 year old female
Reactions: Confusional State, Myoclonus, Neurotoxicity, Drug Effect Decreased, Sedation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Morphine
Administration route: Oral
Indication: Pain
Hydromorphone HCL
Administration route: Oral
Hydromorphone HCL
Administration route: Oral
Fentanyl
Hydromorphone HCL
Administration route: Oral
Indication: Pain
MS Contin
Fentanyl
Indication: Pain
Fentanyl
Fentanyl
MS Contin
Indication: Pain
Morphine
Administration route: Oral
Methadone HCL
Administration route: Oral
Methadone HCL
Administration route: Oral
Indication: Pain
Possible MS Contin side effects in 39 year old male
Reported by a physician from United States on 2011-10-10
Patient: 39 year old male
Reactions: Weight Decreased, Confusional State, Bile Duct Obstruction, Drug Effect Decreased, Dysphagia, Anaemia, Hypotension, General Physical Health Deterioration, Neoplasm Progression, Somnolence, Malaise, Cholangitis, Urinary Retention, Hallucination, Muscle Spasms
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Exalgo
Dosage: 32 mg, unk
Indication: Cancer Pain
Start date: 2010-04-01
End date: 2010-06-01
Morphine
Dosage: 20 mg, single
Indication: Pain
Start date: 2010-01-01
End date: 2010-01-01
Fentanyl-100
Dosage: 125 ug/hr, unk
Start date: 2010-06-01
End date: 2010-01-01
Fentanyl-100
Dosage: 150 ug/hr, unk
Start date: 2010-01-01
Fentanyl-100
Dosage: 200 ug/hr, unk
Start date: 2010-01-01
End date: 2010-01-01
Gemcitabine Hydrochloride
Dosage: 3 series of 8 treatments
Indication: Chemotherapy
Start date: 2010-04-01
End date: 2010-07-01
Nsaid's
Dosage: prn pain
Indication: Pain
FEM Protocol
Dosage: 2 series
Start date: 2010-01-01
Fentanyl-100
Dosage: 50 ug/hr, unk
Indication: Cancer Pain
Fentanyl-100
Dosage: unk
Start date: 2010-01-01
End date: 2010-01-01
Fentanyl-100
Dosage: 100 ug/hr, unk
Start date: 2010-01-01
End date: 2010-01-01
Nsaid's
Dosage: regularly administered
Cisplatin
Dosage: 3 series of 8 treatments
Indication: Chemotherapy
Start date: 2010-04-01
End date: 2010-07-01
MS Contin
Dosage: 3 x130 mg
Administration route: Oral
Indication: Cancer Pain
Start date: 2010-10-01
Fentanyl-100
Dosage: 75 ug/hr, unk
End date: 2010-04-01
Fentanyl-100
Dosage: 250 ug/hr, unk
Start date: 2010-01-01
End date: 2010-10-01
MS Contin
Dosage: 3 x 190 mg
Administration route: Oral
End date: 2010-01-01
MS Contin
Dosage: 2 x 90 mg
Administration route: Oral
Start date: 2010-01-01
Morphine Sulfate
Dosage: unk
Indication: Breakthrough Pain
Start date: 2010-01-01
Amitriptyline HCL
Dosage: 2 x 1
Indication: Pain
Other drugs received by patient: Proton Pump Inhibitors
|